documents: FDA-2012-D-0307-0070

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2012-D-0307-0070 FDA FDA-2012-D-0307 Recommendations To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components; Guidance for Industry; Availability Notice Notice of Availability 2022-05-24T04:00:00Z 2022 5 2022-05-24T04:00:00Z 2022-05-25T03:59:59Z 2022-05-25T01:01:14Z 2022-11119 0 0 09000064850dbd5c

Links from other tables